Symposium 13: Sarcopenia in patients with diabetes, chronic kidney disease and cardiac insufficiency

Authors

  • Myriam Cipres University of Buenos Aires, Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/diab.v54i3Sup.324

Keywords:

diabetes, chronic kidney disease, heart failure

Abstract

Symposium 13: Sarcopenia and diabetes

Sarcopenia in patients with diabetes, chronic kidney disease and cardiac insufficiency

KDOQI guidelines (2007) defined renal complication in patients with diabetes caused by hyperglycemia as DKD (diabetic kidney disease). The underdiagnosis of both pathologies leads to the loss of prevention opportunities and adequate medical attention. Professional associations use the recommendation made by ADA for the detention of DKD that consists in evaluating GF (≤ 60mL/min shows kidney damage) or the structural damage (albuminuria ≥30 mg/g creatinine). The risk of Kidney Disease (KD) appearing is multiplied by 25 in patients with diabetes, as it is the main cause of both CKD and the entrance to renal replacement therapy.

Intensive glycemic control has been shown to decrease mortality and the incidence of cardiovascular diseases, to delay the beginning and progression of albuminuria, and to reduce GFR in patients with type 1 and type 2 diabetes.

Author Biography

Myriam Cipres, University of Buenos Aires, Autonomous City of Buenos Aires, Argentina

Bachelor of Nutrition (UBA), specialized in Nephrology

References

-1- Pérez-Escobar MM, Herrera-Cruz N, Pérez-Escobar E. Síndrome de malnutrición, inflamación y aterosclerosis en la insuficiencia renal crónica terminal. Revista Archivo Médico de Camagüey 2017; 21 (3): 409-421

-2- Gracia-Iguacel C, González-Parra E, Barril Cuadrado G, et al. Definiendo el síndrome de desgaste proteico energético en la enfermedad renal crónica: prevalencia e implicaciones clínicas. Nefrología 2014; 34 (4): 425-544.

-3- Carrero JJ, Stenvienkel P, Cuppari L, et al. Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the ISRNM. JRN 2013; 23 (2): 77-90.

-4- EGSOP. Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing 2019; 48: 16-31.

Downloads

Published

2023-01-10

How to Cite

Cipres, M. (2023). Symposium 13: Sarcopenia in patients with diabetes, chronic kidney disease and cardiac insufficiency. Journal of the Argentine Society of Diabetes, 54(3Sup), 50–50. https://doi.org/10.47196/diab.v54i3Sup.324

Issue

Vol. 54 No. 3Sup (2020): September/December 2020

Section

Symposium Part 4

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.

La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.

Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.